Cardiac resynchronization therapy (CRT) is clearly effective in patients with a wide QRS interval, LV systolic dysfunction, left bundle branch block (LBBB), and heart failure. In patients with a non-LBBB, CRT has not been effective (4). However, in a subgroup of patients with prolonged PR intervals (>230 ms), CRT was associated with a 73% reduction in the cumulative risk of heart failure/death (5). However, in patients with a PR interval <230 ms, CRT was associated with a trend toward an increased risk of heart failure/death. It was noted in this study that patients with PR intervals >230 ms had the highest risk of HF/death, whereas the clinical benefit of CRT was greater. In patients with narrow QRS interval (<130 ms) and cardiomyopathy, CRT did not show improvement in exercise capacity, quality of life, New York Heart Association functional class, or LV indexes (6). Subgroup analysis in this study suggested a possible benefit in patients with a PR interval >180 ms (7). Similarly in the COMPANION (Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure) trial, a PR interval >200 ms was associated with 41% increased risk of all-cause mortality or heart failure hospitalization (8).
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A prolonged PR interval is a potentially modifiable risk factor in patients with LV dysfunction and AV asynchrony, but without ventricular dyssynchrony. and honoraria and consulting fees from Biotronik. Dr. Vijayaraman has received consulting fees from Boston Scientific; and honoraria from Medtronic. 2. Crisel RK, Farzaneh-Far R, Na B, Whooley MA.
First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study. Eur Heart J 2011;32:1875-80. 
